Xilio Therapeutics, Inc. (NASDAQ:XLO) filed a Form 8-K with the Securities and Exchange Commission on February 12, 2026, disclosing a material event.
Xilio Therapeutics, Inc.'s stock currently trades at $0.60 with a market capitalization of $37.6M. The Healthcare company's stock moved following the disclosure.